期刊
NUCLEIC ACIDS RESEARCH
卷 35, 期 21, 页码 7372-7388出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkm896
关键词
-
资金
- Intramural NIH HHS Funding Source: Medline
BORIS, like other members of the cancer/testis antigen family, is normally expressed in testicular germ cells and repressed in somatic cells, but is aberrantly activated in cancers. To understand regulatory mechanisms governing human BORIS expression, we characterized its 5-flanking region. Using 5 RACE, we identified three promoters, designated A, B and C, corresponding to transcription start sites at 1447, 899 and 658 bp upstream of the first ATG. Alternative promoter usage generated at least five alternatively spliced BORIS mRNAs with different half-lives determined by varying 5-UTRs. In normal testis, BORIS is transcribed from all three promoters, but 84 of the 30 cancer cell lines tested used only promoter(s) A and/or C while the others utilized primarily promoters B and C. The differences in promoter usage between normal and cancer cells suggested that they were subject to differential regulation. We found that DNA methylation and functional p53 contributes to the negative regulation of each promoter. Moreover, reduction of CTCF in normally BORIS-negative human fibroblasts resulted in derepression of BORIS promoters. These results provide a mechanistic basis for understanding cancer-related associations between haploinsufficiency of CTCF and BORIS derepression, and between the lack of functional p53 and aberrant activation of BORIS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据